Lexicon Pharmaceuticals
LXRX
#6861
Rank
A$1.02 B
Marketcap
A$2.31
Share price
-8.38%
Change (1 day)
2.81%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): A-$0.20

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$0.21. In 2025 the company made an earnings per share (EPS) of A-$0.21 an increase over its 2024 EPS that were of A-$0.97.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.20-3.47%
2025A-$0.21-78.13%
2024A-$0.97-20%
2023A-$1.2131.15%
2022A-$0.92-0%
2021A-$0.9210.91%
2020A-$0.83-145.08%
2019A$1.84-206.09%
2018A-$1.74-5.74%
2017A-$1.84-10.95%
2016A-$2.072640%
2015A-$0.07554-96.34%
2014A-$2.06-2.53%
2013A-$2.12-9.09%
2012A-$2.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
A$28.69-13,664.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$8.90-4,307.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$70.98-33,657.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$7.84 3,607.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$3.91-1,950.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.03022-85.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A-$1.13 435.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A-$0.14-35.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A-$44.25 20,821.43%๐Ÿ‡บ๐Ÿ‡ธ USA